Human Immunoglobulin A2 (IgA2) Antibody

<strong>Human Immunoglobulin A2 (IgA2) Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2015645_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> IgA, ig, iga2, immunoglobulina2, immunoglobulin a2, immunoglobulin, immunoglobulin aII, immunoglobulin a, ig a, IGHA 2, A2m Marker, Ig alpha 2 Chain C Region, IgA Constant Heavy Chain 2, IGHA2, Immunoglobulin Am2, Immunoglobulin Heavy Constant alpha 2._x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Senior BW, Dunlop JI, Batten MR, Kilian M, Woof JM. Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases Infect Immun. 2000 Feb;68(2):463-9._x000D_ 2: von Gunten S, Schneider C, Imamovic L, Gorochov G. Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs Front Immunol. 2023 Mar 28;14:1166821._x000D_ 3: Mes L, Steffen U, Chen HJ, Veth J, Hoepel W, Griffith GR, Schett G, den Dunnen J. IgA2 immune complexes selectively promote inflammation by human CD103(+) dendritic cells Front Immunol. 2023 Mar 16;14:1116435._x000D_ 4: Mestecky J. Immunobiology of IgA Am J Kidney Dis. 1988 Nov;12(5):378-83._x000D_ 5: Sterlin D, Fadlallah J, Slack E, Gorochov G. The antibody/microbiota interface in health and disease Mucosal Immunol. 2020 Jan;13(1):3-11._x000D_ 6: Evers M, Rösner T, Dünkel A, Jansen JHM, Baumann N, Ten Broeke T, Nederend M, Eichholz K, Klausz K, Reiding K, Schewe DM, Kellner C, Peipp M, Leusen JHW, Valerius T. The selection of variable regions affects effector mechanisms of IgA antibodies against CD20 Blood Adv. 2021 Oct 12;5(19):3807-3820._x000D_ 7: Minton K. Feeding IgA(+) plasma cells Nat Rev Immunol. 2022 Nov;22(11):654-655._x000D_ 8: Reinhart D, Kunert R. Upstream and downstream processing of recombinant IgA Biotechnol Lett. 2015 Feb;37(2):241-51._x000D_ 9: Nielsen LK, Dziegiel MH. Recombinant human immunoglobulin (Ig)A1 and IgA2 anti-D used for detection of IgA deficiency and anti-IgA Transfusion. 2008 Sep;48(9):1892-7._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/1880427">10: Loomes LM, Stewart WW, Mazengera RL, Senior BW, Kerr MA. Purification and characterization of human immunoglobulin IgA1 and IgA2 isotypes from serum J Immunol Methods. 1991 Aug 9;141(2):209-18. </a>_x000D_ _x000D_ <strong>Products Related to Human Immunoglobulin A2 (IgA2) Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>